169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
METHOD AND MARKER FOR DIAGNOSING DIABETES MELLITUS
#5402DETECTION OF CONTRAST MEDIUM-INDUCED NEPHROTOXICITY
#5403Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Cardiac Disease
#5404BIOMARKERS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION
#5405Use of Lipocalin 2 in the Regulation of Insulin Sensitivity
#5406METHODS TO IDENTIFY MODULATORS OF B-RAF PROTEIN KINASE AND THEIR USE FOR THE TREATMENT OF ANXIETY AND DEPRESSION
#5407Minimally-invasive measurement of esophageal inflammation
#5408Biomarkers for inflammation of the liver
#5409DIAGNOSIS OF AGE-RELATED MACULAR DEGENERATION USING BIOMARKERS
#5410Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
#5411Methods of assessing Crohn's disease patient phenotype by I2 serologic response
#5412Methods of screening a subject for mutations associated with novel X-linked muscular myopathies
#5413Means and method for predicting diabetes
#5414METHODS OF SELECTING HOST RESISTANT ANIMALS
#5415DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#5416Biological Load Indicator and Method of Measuring Biological Load
#5417USE OF URINARY NGAL TO DISTINGUISH KIDNEY DISEASE AND PREDICT MORTALITY IN SUBJECTS WITH CIRRHOSIS
#5418USE OF URINARY NGAL TO DIAGNOSE UNILATERAL AND BILATERAL URINARY OBSTRUCTION
#5419METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#5420Method for determining inflammatory disease
#5421Method for predicting the risk of disease based on lectin binding
#5422Use of HMGB proteins and nucleic acids that code therefor
#5423Methods and Compositions for Detecting and Treating End-Stage Cardiomyopathy Using Claudin-5
#5424Methods for detection of biological substances
#5425METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#5426Methods for diagnosing episodic movement disorders and related conditions
#5427MEASUREMENT OF ARYLESTERASE ENZYMATIC ACTIVITY AND ASSESSMENT OF GENETIC POLYMORPHISMS LOCATED IN THE PON1 GENE AS A DIAGNOSTIC TOOL IN AUTISM-SPECTRUM DISORDERS
#5428HYPOALLERGENIC PROTEINS
#5429MODULATORS OF ODORANT RECEPTORS
#5430COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING IRRITABLE BOWEL SYNDROME
#5431Method for assaying sepsis in humans
#5432Methods for detecting and analyzing N-glycolylneuraminic acid (Neu5Gc) in biological materials
#5433Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#5434BIOMARKER OF ALLERGIC DISEASE AND USE OF THE SAME
#5435METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE
#5436METHODS OF IDENTIFYING AND USING SNAIL1 INHIBITORY COMPOUNDS IN CHONDRODYSPLASIA TREATMENT AND PREPARATION OF PHARMACEUTICAL COMPOSITIONS
#5437BIOMARKERS OF SIRTUIN ACTIVITY AND METHODS OF USE THEREOF
#5438MIA-2 PROTEIN
#5439Use of IMP3 as a Prognostic Marker for Cancer
#5440Biomarkers for Appetite Regulation
#5441Diagnostic Test to Exclude Significant Renal Injury
#5442PROCESS AND MARKERS FOR THE DIAGNOSIS OF KIDNEY DISEASES
#5443BIOMARKERS ASSOCIATED WITH NEPHROPATHY
#5444Fibrosis biomarker assay
#5445Recombinant 15-kDa polypeptide and use of same in detecting human infection with
#5446Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#5447Deletion of unwanted reply messages in e-mail printing
#5448Biochemical markers for acute pulmonary embolism
#5449Methods for the detection and monitoring of congestive heart failure
#5450Peptide Fingerprint from the Degradation of Elastin by HNE
#5451Systems and methods for analyzing persistent homeostatic perturbations
#5452Immunoassay for quantification of an unstable antigen selected from BNP and proBNP
#5453Histochemical and biomarker for liver fibrosis
#5454Method for the in Vitro Detection of a Predisposition to the Development of Alterations in Ovarian Function
#5455DIAGNOSTICS AND THERAPEUTICS BASED ON CIRCULATING PROGENITOR CELLS
#5456Polypeptide Markers for the Early Recognition of the Rejection of Transplanted Kidneys
#5457Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem cells
#5458Biomarkers for depression and methods using the same
#5459Urine and serum biomarkers associated with diabetic nephropathy
#5460METABOLIC MARKERS OF DIABETIC CONDITIONS AND METHODS OF USE THEREOF
#5461Multi-analyte analysis of saliva biomarkers as predictors of periodontal and pre-implant disease
#5462COMPOSITIONS AND MULTIPLEX ASSAYS FOR MEASURING BIOLOGICAL MEDIATORS OF PHYSIOLOGICAL HEALTH
#5463Anti-system ASC amino acid transporter 2 (ASCT2) antibody
#5464Group B polypeptides nucleic acids and therapeutic compositions and vaccines thereof
#5465Glutamate receptor antagonists and methods of use
#5466Methods of treating inflammatory and autoimmune diseases with natalizumab
#5467COMPOSITIONS AND METHODS RELATED TO PROTEIN DISPLACEMENT THERAPY FOR MYOTONIC DISTROPHY
#5468Compositions and Methods for Diagnosing and Assessing Inflammatory Myopathies
#5469Biomarkers for Detection of Neonatal Sepsis in Biological Fluid
#5470TRANSCRIPTOMIC BIOMARKER OF MYOCARDITIS
#5471Diagnostic kit for detecting urinary protein of a cat after cauxin removal
#5472Non-invasive marker for liver function and disease
#5473GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF
#5474TISSUE REJECTION BIOMARKERS
#5475Diagnosis and monitoring of renal failure using peptide biomarkers
#5476METHODS OF USING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE TL1A GENE TO PREDICT OR DIAGNOSE INFLAMMATORY BOWEL DISEASE
#5477Method for screening a test substance for activating a receptor associated with FGF 21 activity
#5478DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#5479Methods and Devices for Diagnosis of Appendicitis
#5480Chimeric DRG11-responsive (DRAGON) polypetides
#5481Risk markers for cardiovascular disease
#5482CONFORMATION AND ACTIVITY OF GBETA5 COMPLEXES
#5483MOLECULES INVOLVED IN REGULATION OF OSTEOBLAST ACTIVITY AND OSTEOCLAST ACTIVITY, AND METHODS OF USE THEREOF
#5484Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease
#5485USE OF COAGULATION PROTEINS TO LYSE CLOTS
#5486ISCHEMIC BIOMARKERS AND THEIR USE TO PREDICT ADVERSE NEUROLOGICAL EVENTS FROM SURGERY
#5487Methods for detecting coronary artery disease
#5488Method of determining 1,5-anhydroglucitol, and reagent composition for determining 1,5-anhydroglucitol
#5489Use of hematopoietic growth factor inducible neurokinin-1 (HGFIN) as a biomarker for renal injury or renal disease
#5490Quantification of non-reducing end glycan residual compounds
#5491NOVEL NOTCH-ORIGIN POLYPEPTIDES AND BIOMARKERS AND REAGENTS USING THE SAME
#5492Making a prognosis in cases of cardiac disease using a combination of markers
#5493Diagnosis and Prevention of Fetal Heart Disease
#5494Endometrial biomarkers
#5495METHODS AND SYSTEMS FOR PROSTATE HEALTH MONITORING
#5496ASSESSING RISK OF CARDIAC INTERVENTION IN PATIENTS SUFFERING FROM STABLE CORONARY HEART DISEASE BASED ON GDF-15
#5497BLOOD CELL SEPARATION
#5498CLIP INHIBITORS AND METHODS OF MODULATING IMMUNE FUNCTION
#5499C5 Antigens and Uses Thereof
#5500Probe for a hair cell, and labelling method for a hair cell using the probe for a hair cell
#5501Laminin receptor 1 precursor protein (37LRP) epitope delineated by an hepatocellular carcinoma specific antibody
#5502Means and method for diagnosing diabetes
#5503IL1RL-1 as a cardiovascular disease marker and therapeutic target
#5504H-FABP as early predictor of myocardial infarction
#5505Biomarkers for chronic vascular dysfunction
#5506METHOD FOR REDUCING THE LIKELIHOOD OF PRETERM LABOR IN A SUBJECT IN NEED THEREOF
#5507METHOD FOR REDUCING THE LIKELIHOOD OF PREECLAMPSIA IN A SUBJECT IN NEED THEREOF
#5508Methods for diagnosing cancer and decreasing metastasis by cancer cells
#5509Assays and methods using biomarkers
#5510Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
#5511Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNP
#5512DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia
#5513Therapeutic agent for ulcerative colitis
#5514System and Method for Identifying Biomarkers in Ocular Fluid That Are Indicative of Ocular Disease
#5515METHODS FOR EVALUATING OSTEOARTHRITIS RISK
#5516METHOD OF DIAGNOSING AND TREATING ASTHMA
#5517Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics
#5518Use of β-2-microglobulin to assess glomerular alterations and damage in the kidney
#5519Galectin-3 Immunoassay
#5520Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients
#5521BINDING OF COMPLEMENT FACTOR H TO C-REACTIVE PROTEIN
#5522Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95
#5523Surfactant Protein D is a Biomarker for Steroid Responsiveness in Asthma and Chronic Obstructive Pulmonary Disease
#5524In vitro assay for early diagnosis of diabetes mellitus type 1
#5525Method for the rapid diagnosis of targets in human body fluids using undiluted samples
#5526OXGR1 AGONISTS FOR USE IN THERAPIES FOR METABOLIC DISORDERS
#5527Method of treating diabetes
#5528Metabolic syndrome and HPA axis biomarkers for major depressive disorder
#5529Methods and kits for determining von willebrand factor activity in the absence of ristocetin
#5530Methods and Devices for Diagnosis of Appendicitis
#5531Method of Identifying Risk for Thyroid Disorder
#5532METHODS FOR USING ANTIBODIES AND ANALOGS THEREOF
#5533METHOD FOR IDENTIFICATION OF SOMATIC STEM CELLS
#5534BIOMARKERS USEFUL IN LIVER FIBROSIS DIAGNOSIS
#5535METHOD FOR DETECTING A CHRONIC INFLAMMATORY-ASSOCIATED DISEASE
#5536Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory Disease
#5537Target protein and target gene in drug designing and screening method
#5538Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
#5539Methods for detecting diabetic nephropathy comprising measuring the expression of Smad1
#5540Compositions and methods for inhibiting G protein signaling
#5541Methods of Quantitatively Assessing Inflammation with Biosensing Nanoparticles
#5542Glycated Insulin as a Biomarker for Diagnosis and Monitoring of Diabetes
#5543Tandem mass spectrometry for detecting and/or screening for conditions associated with altered sterols
#5544DETECTION OF A BLOOD COAGULATION ACTIVITY MARKER IN A BODY FLUID SAMPLE
#5545Double stranded RNA receptor (dsRNA-R) and methods relating thereto
#5546Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction
#5547Polypeptide Markers for the Diagnosis and Evaluation of Vascular Diseases
#5548Biomarkers for Differentiating Between Type 1 and Type 2 Diabetes
#5549Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
#5550METHODS FOR DETECTION OF PREECLAMPSIA
#5551Method to increase specificity and/or accuracy of lateral flow immunoassays
#5552TRANSCRIPTOMIC BIOMARKERS FOR INDIVIDUAL RISK ASSESSMENT IN NEW ONSET HEART FAILURE
#5553BLOOD DIAGNOSIS METHOD FOR DIALYSIS PATIENT AND DIALYSIS MACHINE
#5554Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseases
#5555Monoclonal antibody and use thereof
#5556METHOD FOR DIAGNOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36
#5557Methods and kits for the rapid determination of patients at high risk of death during severe sepsis and septic shock
#5558METHOD FOR DETECTING HUMAN PARVOVIRUS ANTIGEN
#5559Biomarkers for ovarian cancer
#5560Tissue Rejection
#5561METHODS OF DIAGNOSING CARDIOVASCULAR DISEASE
#5562Compositions and Methods for Treating or Preventing Ophthalmic Disease
#5563Allergen fragments
#5564Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
#5565COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ENDOTHELIAL DYSFUNCTION
#5566HUMAN BIOMARKER HYPERMAPPING FOR DEPRESSIVE DISORDERS
#5567Method for Diagnosing Diseases Based on Levels of Anti-Glycan Antibodies
#5568Soluble Human M-CSF Receptor and Uses Thereof
#5569Method for predicting cancer and other diseases
#5570Regulation of lipid droplet formation by modulation of FIT1 and FIT2 and uses thereof
#5571METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME
#5572METHOD OF SCREENING COMPOUND USEFUL IN TREATING ALLERGIC DISEASE
#5573POTENTIATION OF CELLULAR IMMUNITY USING HISTONE DEACETYLASE (HDAC) INHIBITORS.
#5574Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
#5575METHODS FOR IDENTIFYING AGENTS AND THEIR USE FOR THE PREVENTION OR STABILIZATION OF FIBROSIS
#5576DIAGNOSIS AND RISK STRATIFICATION OF CARDIAC INSUFFICIENCY USING NEUROPHYSIN
#5577Autophagy and phospholipidosis pathway assays
#5578USE OF NOVEL CYTOKINE RECEPTORS AS BIOMARKERS AND THERAPEUTIC TARGETS IN HUMAN CANCER
#5579Methods for Determining Collateral Artery Development in Coronary Artery Disease
#5580Recombinant merozoite surface proteins 4 and 5 and their use
#5581Prevention of tissue ischemia, related methods and compositions
#5582METHOD AND MEANS FOR TREATMENT OF OSTEOARTHRITIS
#5583Detection and therapy of bacterial infection caused by
#5584Detection of HIV-related proteins in urine
#5585Methods and compositions for diagnosis and prognosis of renal artery stenosis
#5586Methods for determining aged based accumulation of senescent cells using senescence specific DNA damage markers
#5587Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
#5588DETECTION OF ORGAN REJECTION
#5589METHODS TO DECREASE THE RISK OF METABOLIC SYNDROME POST IMMUNIZATION
#5590Toll-LIke Receptor 4 Deficiency and Downstream Effectors Cause Pulmonary Emphysema
#5591Biochemical markers for acute pulmonary embolism
#5592Biomarkers for early detection of ovarian cancer
#5593Method for diagnosing kidney disease comprising detecting the level of annexin A2
#5594Genemap of the human genes associated with crohn's disease
#5595Method for reducing the risk of spontaneous abortion in a human female subject
#5596METHOD OF EVALUATING COMPOUND EFFICACIOUS IN TREATING OBESITY BY USING Slc25a10
#5597Methods for treating pain by inhibition of the SCN9A channel
#5598Methods for identifying and monitoring drug side effects
#5599Method for diagnosis of a disease involving an anti-endothelin-receptor antibody
#5600METHOD OF DETERMINING THE RISK OF SCOLIOSIS
#5601Sclerostin and the inhibition of Wnt signaling and bone formation
#5602Methods for treating and diagnosing fibrotic and fibroproliferative diseases
#5603Assay
#5604DIAGNOSIS METHOD FOR FATTY LIVER DISEASE, DIAGNOSIS APPARATUS, DIAGNOSIS PROGRAM, DIAGNOSTIC AGENT, AND METHOD FOR SCREENING FOR THERAPEUTIC AGENT FOR FATTY LIVER DISEASE
#5605Methionine sulfoxide antibodies
#5606Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#5607Polypeptide Markers for the Diagnosis and Evaluation of Pelvi-Ureteric Junction Obstruction (PUJO)
#5608ASSESSING MAMMALS FOR VASCULAR DISEASES AND VALVULAR DISEASES
#5609BIOMARKERS FOR DIAGNOSING MULTIPLE SCLEROSIS, AND METHODS THEREOF
#5610Methods for determining signal transduction activity in tumors
#5611Method of measuring PTX3 with high sensitivity
#5612TLE3 as a marker for chemotherapy
#5613USE OF ADAMTS4 GENE AND PROTEIN POLYMORPHISMS
#5614Type I interferon-inducible proteins to detect viral infection
#5615METHOD OF EVALUATING IBD, AMINO ACID DATA PROCESSOR, AMINO ACID DATA-PROCESSING METHOD, AMINO ACID DATA-PROCESSING SYSTEM, AMINO-ACID DATA-PROCESSING PROGRAM AND RECORDING MEDIUM
#5616Compositions and Methods of Their Use for Improving the Condition and Appearance of Skin
#5617Methods and compositions for treating and diagnosing diseases
#5618HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERS
#5619Cosmetic use of chitinase-type proteins
#5620Methods for the Diagnosis and Treatment of Female Infertility Using Molecular Markers
#5621Galectin-3-Binding Protein as a Biomarker of Cardiovascular Disease
#5622Screening methods for transfusion related acute lung injury (TRALI)
#5623DIAGNOSIS OF PULMONARY AND/OR CARDIOVASCULAR DISEASE
#5624IDENTIFYING PATIENTS AT RISK FOR LIFE THREATENING ARRHYTHMIAS
#5625Colorimetric determination of somatic cell count in milk
#5626METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#5627Assessment of patients with sepsis to determine a requirement for therapeutic intervention with an anti-inflammatory and/or anticoagulatory agent
#5628TIMP-4 AS A BIOMARKER FOR THE DIAGNOSIS OF CARDIAC INSUFFICIENCY
#5629Antibody-Based Protein Microarray to Detect Long-Term Stress In Animal Tissues
#5630Tuberculosis diagnostic test
#5631Compositions and methods for promoting or inhibiting angiogenesis
#5632INHIBITION OF PDE2A
#5633Diagnostic test for renal injury
#5634Diagnosis and risk stratification by determining the marker CT-proADM
#5635COMPOSITIONS AND METHODS FOR TISSUE-BASED PROTEIN TRUNCATION TEST FOR DISEASE DIAGNOSIS
#5636DIAGNOSIS AND RISK ASSESSMENT OF PANCREATIC DIABETES USING MR-PROADM
#5637COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#5638Methods for diagnosing and treating a heart condition in a patient
#5639SCREENING METHOD
#5640Risk stratification for acute coronary syndrome by determining copeptin
#5641METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#5642METHODS FOR DIAGNOSING OSTEOARTHRITIS
#5643Modulators of UDP-glucose ceramide glucosyltransferase for treating acne or hyperkeratinization
#5644Compositions and Methods to Treat Bone Related Disorders
#5645Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
#5646DIAGNOSIS OF HYPERINSULINEMIA AND TYPE II DIABETES AND PROTECTION AGAINST SAME BASED ON PROTEINS DIFFERENTIALLY EXPRESSED IN SERUM
#5647DIFFERENTIAL GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL ANGIOGENESIS
#5648PREDICTIVE BIOMARKERS FOR CHRONIC ALLOGRAFT NEPHROPATHY
#5649MODULATING ENDOPLASMIC RETICULUM STRESS IN THE TREATMENT OF TUBEROUS SCLEROSIS
#5650Antibodies that bind human OX2 receptors
#5651Fatty acid pattern analysis for predicting acute coronary syndrome
#5652APPLICATION OF SURFACE PLASMON RESONANCE TECHNOLOGY TO MATERNAL SERUM SCREENING FOR CONGENITAL BIRTH DEFECTS
#5653Salivary biomarkers for Sjögren's syndrome
#5654Modulators of lanosterol synthetase for treating acne or hyperseborrhea
#5655METHODS FOR DIAGNOSIS AND TREATMENT OF CROHN'S DISEASE
#5656Benzoxazole derivatives
#5657Protein activity modification
#5658DETECTION OF NGAL IN CHRONIC RENAL DISEASE
#5659IL-8 AS BIOMARKER FOR THE DETECTION OF UROLITHIASIS
#5660METHOD OF QUANTITATIVE DETERMINATION OF ANTIGEN PROTEIN AND QUANTITATIVE DETERMINATION KIT THEREFOR
#5661Method for diagnosing and treating Crohn's disease
#5662Compositions and Methods for Modulating Osteoblast Cell Differentiation and Bone Generation Through HIF-1a
#5663Methods of using F-spondin as a biomarker for cartilage degenerative conditions and bone diseases
#5664Method of assessing progress of kidney regeneration
#5665Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
#5666METHOD TO IDENTIFY AND TREAT SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID
#5667Timp-2 as target/marker of beta cell failure
#5668Methods for diagnosis, prognosis and methods of treatment
#5669RBP4 in insulin sensitivity/resistance, diabetes, and obesity
#5670Diagnosis of cardiovascular disease
#5671Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
#5672Compositions and methods to control angiogenesis with cupredoxins
#5673Methods of treatment using ammonia-scavenging drugs
#5674Bi-specific monoclonal antibody (specific for both CD3 and CD11B) therapeutic drug
#5675METHOD FOR QUANTITATIVE MEASUREMENT OF CARDIAC BIOCHEMICAL MARKERS
#5676GLAUCOMA BIOMARKER
#5677Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
#5678System for Glycated Protein Detection
#5679Detecting infection in reduced pressure wound treatment
#5680Diagnostic marker for diabetic vascular complications
#5681POLYCLONAL-MONOCLONAL ELISA ASSAY FOR DETECTING N-TERMINUS PRO-BNP
#5682Gene Expression Profiles Associated with Asthma Exacerbation Attacks
#5683Means and methods for diagnosing and/or treating a subject at risk of developing heart failure
#5684METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME
#5685Methods and compositions for the treatment of symptoms of Williams Syndrome
#5686Methods for detecting a infection
#5687METHODS AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND DISORDERS
#5688BIOFLUID METABOLITE PROFILING AS A TOOL FOR EARLY PREDICTION OF AUTOIMMUNITY AND TYPE 1 DIABETES RISK
#5689Use of at least one isoform of progesterone receptor membrane component 1 (PGRMC1)
#5690METHOD FOR MEASURING PLASMA LEVELS OF LONG PENTRAXIN PTX3
#5691Diagnostic kits to detect SP22 and SP22 antibodies
#5692MUTATIONS IN CAPILLARY MORPHOGENESIS GENE-2 (CMG-2) AND USE THEREOF
#5693Synthetic active peptide fragments
#5694Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
#5695Methods to predict and prevent resistance to taxoid compounds
#5696Protection against and treatment of age related macular degeneration
#5697USES OF HUMAN ZVEN PROTEINS AND POLYNUCLEOTIDES
#5698USES OF HUMAN ZVEN PROTEINS AND POLYNUCLEOTIDES
#5699USES OF HUMAN ZVEN PROTEINS AND POLYNUCLEOTIDES
#5700Diagnostic Test to Exclude Significant Renal Injury